Fielmann Atrea Excellence 1 Month Multifocal Contact Lenses: Advanced Solution for Presbyopia in Europe
27.03.2026 - 11:20:56 | ad-hoc-news.deFielmann offers the Atrea Excellence 1 Month Multifocal contact lenses as a key product for individuals with presbyopia, enabling seamless vision correction across near, intermediate, and far distances without glasses. This positions the lenses as a convenient alternative in Fielmann's optical offerings, relevant for European markets where the company maintains a strong retail presence. For North American investors, it highlights Fielmann Group AG's (ISIN: DE0005772206) diversification beyond spectacles into contact lenses.
As of: 27.03.2026
By Dr. Elena Vargas, Senior Optics Market Analyst: Fielmann's contact lens innovations underscore the growing demand for multifocal solutions amid aging populations in Europe.
Current Availability and Product Features
The Atrea Excellence 1 Month Multifocal lenses are currently available through Fielmann stores and online in Germany, Austria, and Switzerland. Designed specifically for presbyopia, or age-related farsightedness, these monthly replacement lenses allow users to see clearly at all distances.
Each pack contains 6 lenses, suitable for one eye over a month, with a usage period of 30 days after opening. This makes them practical for daily wear, offering a balance of convenience and cost for regular users.
Presbyopia affects a significant portion of the population over 40, creating steady demand for such multifocal options. Fielmann's stocking of these lenses supports its role as a comprehensive optical provider.
Official source
The official product page or announcement offers the most direct context for the latest development around Atrea Excellence 1 Month Multifocal.
Visit official product pageDesign and Technology Behind Multifocal Lenses
Multifocal contact lenses like the Atrea Excellence incorporate progressive zones that adjust focus automatically based on the wearer's gaze. This technology eliminates the need to switch between reading and distance glasses, enhancing user comfort.
The lenses feature a multifocal design optimized for natural vision transitions. Materials used are breathable and deposit-resistant, supporting all-day wear without irritation for most users.
Such advancements stem from ongoing research in contact lens optics, where simultaneous vision principles allow multiple focal points on a single lens surface. Fielmann selects products that meet high standards for clarity and durability.
For presbyopia patients, this means reduced visual fatigue and improved quality of life. The product's positioning appeals to active adults seeking discreet vision correction.
Market Position in European Optometry
Fielmann operates over 900 stores across Europe, primarily in Germany, Austria, and Switzerland, where contact lenses complement its core spectacles business. The Atrea Excellence fits into this ecosystem as an accessible multifocal option.
Europe's optical market emphasizes quality and affordability, with contact lenses gaining share as consumers prefer non-invasive alternatives to surgery or bifocals. Fielmann's pricing strategy, such as discounted packs, supports market penetration.
Competitors include major brands like Johnson & Johnson and CooperVision, but Fielmann's integrated retail model provides fitting services that enhance adoption. This vertical integration strengthens customer loyalty.
The presbyopia segment is expanding due to demographic shifts, with Europe's aging population driving demand. Fielmann's focus here aligns with long-term trends in eye care.
Reactions and market sentiment
Strategic Role in Fielmann's Portfolio
Contact lenses represent a diversification for Fielmann, moving beyond traditional eyewear to capture more of the vision correction market. The Atrea Excellence exemplifies this by targeting presbyopia, a common condition underserved by glasses alone.
The company's optical and audiology segments benefit from cross-selling opportunities. Customers visiting for lenses often explore hearing aids or frames, boosting overall revenue.
Innovation in contact lenses supports Fielmann's reputation for quality. By offering monthly multifocals, it caters to users preferring replacement schedules that balance hygiene and economy.
This product line contributes to portfolio resilience, as contact lenses have higher repeat purchase rates compared to one-time spectacle buys. It enhances customer retention in competitive markets.
Benefits and User Considerations
Users report improved versatility with Atrea Excellence lenses, suitable for work, driving, and reading without interruptions. The design minimizes halos and glare, common multifocal drawbacks.
Proper fitting is essential, as Fielmann opticians assess parameters like base curve and diameter for optimal comfort. This professional service differentiates retail chains from online-only sellers.
Maintenance involves daily cleaning and monthly replacement to prevent infections. Suitable for most presbyopia cases, though not ideal for severe dry eye without consultation.
Compared to daily disposables, monthly lenses offer cost savings for committed wearers. They appeal to those transitioning from glasses seeking freedom of movement.
Health benefits include better peripheral vision than bifocals. Regular eye exams ensure ongoing suitability as presbyopia progresses.
Competition and Market Dynamics
The multifocal contact lens market features players like Alcon and Bausch + Lomb, emphasizing aspheric optics for sharper vision. Fielmann's Atrea line competes on price and availability.
European regulations ensure high safety standards, with CE marking required. Fielmann complies fully, building consumer trust.
Growth drivers include rising screen time exacerbating near-vision issues. Hybrid work lifestyles favor all-distance correction.
Challenges involve supply chain for lens materials amid global disruptions. Fielmann's scale aids stability.
Online sales growth pressures physical stores, but personalized fittings remain a moat. Fielmann adapts with omnichannel strategies.
Risks and Future Outlook
Potential risks include material sensitivities affecting a minority of users. Allergic reactions or poor fit can occur, underscoring professional oversight.
Market saturation in mature regions like Germany requires innovation. Fielmann invests in R&D for next-gen lenses.
Demographic tailwinds persist, with presbyopia prevalence rising. Expansion into audiology may indirectly support optical growth.
Sustainability concerns push for eco-friendly packaging. Fielmann monitors trends toward recyclable materials.
Overall, the Atrea Excellence reinforces Fielmann's position in a stable sector. Steady demand supports long-term viability.
Investor Context for Fielmann Group AG
Fielmann Group AG (ISIN: DE0005772206) issues shares backing the operating business, which spans optics and acoustics. Contact lenses like Atrea Excellence contribute to revenue diversification.
North American investors may note the company's European focus, with stable growth from retail density. Portfolio expansion mitigates spectacle cyclicality.
Financial health relies on foot traffic and e-commerce. Multifocals signal adaptability to consumer shifts.
This section provides issuer context only; product performance drives operational insights.
Disclaimer: Not investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis Fielmann Kontaktlinsen Aktien ein!
Für. Immer. Kostenlos.

